Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,00
KB0,00
PKN66,2566,3-0,47
Msft2,22
Nokia3,4193,4450,48
IBM0,62
Mercedes-Benz Group AG71,7271,750,94
PFE0,40
04.05.2024 2:04:00
Indexy online
AD Index online
select
AD Index online
 

  • 29.04.2024 10:18:20
Adv Med Sol (AMSU.F, Frankfurt)
Závěr k 3.5.2024 Změna (%) Změna (EUR) Objem obchodů (EUR)
2,24 -0,88 -0,02 59
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 05.05.2024
Popis společnosti
Obecné informace
Název společnostiAdvanced Medical Solutions Group plc
TickerAMS
Kmenové akcie:Ordinary Shares
RICAMSU.L
ISINGB0004536594
Poslední známé roční výsledky31.12.2023
Poslední známé čtvrtletní výsledky31.12.2023
Počet zaměstnanců k 30.06.2023 800
Akcie v oběhu k 01.05.2024 217 412 434
MěnaGBP
Kontaktní informace
UlicePremier Park, 33 Road One
MěstoWINSFORD
PSČCW7 3RT
ZeměUnited Kingdom
Kontatní osoba 
Funkce kontaktní osoby 
Telefon441 606 863 500
Fax441606863600

Business Summary: Advanced Medical Solutions Group plc is a United Kingdom-based developer and manufacturer of tissue-healing technology, focused on quality outcomes for patients. The Company offers a range of surgical products, including tissue adhesives, sutures, haemostats, internal fixation devices, bone substitutes and internal sealants, which it markets under LiquiBand, RESORBA, LiquiBandFix8, LIQUIFIXTM and SEAL-G brands. The Company also supplies wound care dressings such as silver alginates, alginates and foams through its ActivHeal brand as well as under white label. Its Surgical Business Unit includes tissue adhesives, sutures, biosurgical devices and internal fixation devices. The Woundcare Business Unit is comprised of multi-product portfolio of advanced wound care dressings and a portfolio of specialist medical bulk materials and multi-layer wound care products. Its products are manufactured in the United Kingdom, Germany, France, the Netherlands, the Czech Republic and Israel.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2023, Advanced Medical Solutions Group plc revenues increased 2% to L126.2M. Net income decreased 22% to L15.9M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income was offset by Administration costs increase of 7% to L50.7M (expense). Dividend per share remained flat at L0.02.
Odvětvová klasifikace
TRBC2012Medical Supplies
RBSS2004Medical Equipment, Supplies & Distribution
MGINDUSTRYMedical Equipment & Supplies
MGSECTORHealthcare
NAICSSurgical and Medical Instrument Manufacturing
NAICSSurgical Appliance and Supplies Manufacturing
NAICSPharmaceutical Preparation Manufacturing
NAICSResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
NAICSDrugs and Druggists' Sundries Merchant Wholesalers
NAICS2007Surgical & Medical Instrument Mfg
NAICS2007Surgical Appliance & Supplies Mfg
NAICS2007Pharmaceutical Preparation Mfg
NAICS2007Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
NAICS2007Drugs and Druggists' Sundries Merchant Wholesalers
NAICS1997Surgical and Medical Instrument Manufacturing
NAICS1997Surgical Appliance and Supplies Manufacturing
NAICS1997Pharmaceutical Preparation Manufacturing
NAICS1997Research and Development in the Physical, Engineering, and Life Sciences
NAICS1997Drug, Drug Proprietaries and Druggists' Sundries Wholesalers
SICSurgical And Medical Instruments
SICSurgical Appliances And Supplies
SICPharmaceutical Preparations
SICCommercial Physical Research
SICDrugs/proprietaries/sundries



  • Poslední aktualizace: 05.05.2024
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Chief Executive Officer, Executive DirectorAndrew Meredith-01.01.2011
Chief Financial Officer, Executive DirectorEddie Johnson-01.01.2021
Vice President - Corporate Business DevelopmentBrian Dowd-01.01.2022
Group Human Resources DirectorCathy Tomlinson-
IT DirectorSimon Coates-
Group R&D DirectorAndy Donnelly-
Group Quality Assurance/Regulatory Affairs (QA/RA) DirectorRose Guang-
Business Unit Director - SurgicalRoss McDonald-
Business Unit Director - WoundcareBecky Walmsley-
Company SecretaryOwen Bromley-01.01.2021